Lisata Therapeutics, Inc. (LSTA)
Lisata Therapeutics Market Cap : 11.03M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 11.03M |
| November 12, 2026 | 11.67M |
| November 11, 2026 | 10.94M |
| November 10, 2026 | 9.301M |
| November 09, 2026 | 10.21M |
| November 06, 2026 | 9.393M |
| November 05, 2026 | 9.042M |
| November 04, 2026 | 9.666M |
| November 03, 2026 | 9.940M |
| November 02, 2026 | 9.210M |
| October 30, 2026 | 9.301M |
| October 29, 2026 | 9.210M |
| October 28, 2026 | 9.666M |
| October 27, 2026 | 9.301M |
| October 26, 2026 | 9.666M |
| October 23, 2026 | 9.082M |
| October 22, 2026 | 9.165M |
| October 21, 2026 | 9.575M |
| October 20, 2026 | 9.484M |
| October 19, 2026 | 9.119M |
| October 16, 2026 | 9.393M |
| October 15, 2026 | 9.757M |
| October 14, 2026 | 9.301M |
| October 13, 2026 | 9.848M |
| October 12, 2026 | 9.575M |
| Date | Value |
|---|---|
| October 09, 2026 | 9.666M |
| October 08, 2026 | 10.94M |
| October 07, 2026 | 10.67M |
| October 06, 2026 | 11.03M |
| October 05, 2026 | 11.49M |
| October 02, 2026 | 13.40M |
| October 01, 2026 | 13.59M |
| September 30, 2026 | 13.13M |
| September 29, 2026 | 13.40M |
| September 28, 2026 | 13.68M |
| September 25, 2026 | 14.41M |
| September 24, 2026 | 13.68M |
| September 23, 2026 | 13.09M |
| September 22, 2026 | 13.50M |
| September 21, 2026 | 14.23M |
| September 18, 2026 | 15.50M |
| September 17, 2026 | 15.87M |
| September 16, 2026 | 13.40M |
| September 15, 2026 | 14.04M |
| September 14, 2026 | 14.23M |
| September 11, 2026 | 14.86M |
| September 10, 2026 | 14.96M |
| September 09, 2026 | 17.33M |
| September 08, 2026 | 16.96M |
| September 04, 2026 | 15.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.240B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Anika Therapeutics, Inc. | 179.48M |
| Savara, Inc. | 953.69M |
| Arrowhead Pharmaceuticals, Inc. | 6.743B |
Market Cap Related Metrics
| PS Ratio | 109.66 |
| Price to Book Value | 1.710 |
| Price | 1.21 |
| Earnings Yield | -155.7% |